Amphotericin B in cryptococcal meningitis. Long-term results of treatment.
about
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.Cryptococcosis after renal transplantation: report of ten casesPotentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).Antibody immunity and invasive fungal infectionsMonoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.Cerebral cryptococcosis in Malaysia.Current concepts in cryptococcosis.Cryptococcal meningitis complicating remote skull fracture.Cryptococcosis in a cancer hospital: clinical and pathological correlates in forty-six patients.The place of elective vitrectomy in the management of patients with Candida endophthalmitis.A role for B cells in resistance to Cryptococcus neoformans in mice.Opportunistic/nosocomial infections. Treatment and developmental therapeutics. I. Cryptococcosis.New diagnostic and treatment techniques in cryptococcal meningitis.Cryptococcosis. A cause of calcified intracranial mass lesions.Cryptococcal meningitis in a child with hyperimmunoglobulin E syndrome.Therapy of deep-seated fungal infections with 5-fluorocytosine.Editorial: Cryptococcosis and 5-fluorocytosine.Immunology of Cryptococcal Infections: Developing a Rational Approach to Patient Therapy.
P2860
Q30424017-A107D039-04F9-4853-9B92-31199B3F607AQ33790656-5F791C92-AB87-409E-BFCA-1832785FDDCEQ34256623-AE51EF5A-FB35-41C4-B7D6-2F2C9E28ACDFQ34768226-07950938-D382-4200-8DD2-B0E03F2DF109Q35447692-D6319A7A-61C5-4D77-AE4A-A0A1AFBB05FDQ35775466-5910BCF5-D84B-456F-BEC7-11580567D281Q37042549-E6AD75CE-FCD4-4E61-B4BA-FAA539DD506BQ38229538-B5360EE9-20B5-44DE-B0C7-F614348A261DQ39330825-67878F39-D940-4CC3-97E4-C8537B2F911DQ39620728-5161478B-903F-4F38-8B7C-1E6338E6C480Q39724410-50948725-A301-4BC5-8431-AC889195A688Q39833183-461DFAF6-7F52-469F-ACA3-F30E6850E6DFQ40840468-CD5270A4-BD52-454F-B1FA-4478308AFA3FQ42101424-5C94E1FF-4FE8-4DAB-816A-B8F6501C023DQ42222961-24D2DAE2-2C7F-4657-A6A8-A3475CF02627Q44398693-ADC84F81-576E-44DC-AED9-CD44CBDAC0E3Q54633763-77A547B9-1DCF-4D6E-888F-9B8C3BCB0F4FQ54637449-6B60D879-A763-4FB2-91FA-09C3C20301E5Q54953513-94CC712C-FC59-4D25-B002-B43CB91BF5DE
P2860
Amphotericin B in cryptococcal meningitis. Long-term results of treatment.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh
1969年學術文章
@zh-hant
name
Amphotericin B in cryptococcal meningitis. Long-term results of treatment.
@en
Amphotericin B in cryptococcal meningitis. Long-term results of treatment.
@nl
type
label
Amphotericin B in cryptococcal meningitis. Long-term results of treatment.
@en
Amphotericin B in cryptococcal meningitis. Long-term results of treatment.
@nl
prefLabel
Amphotericin B in cryptococcal meningitis. Long-term results of treatment.
@en
Amphotericin B in cryptococcal meningitis. Long-term results of treatment.
@nl
P2093
P1476
Amphotericin B in cryptococcal meningitis. Long-term results of treatment.
@en
P2093
P304
P356
10.7326/0003-4819-71-6-1079
P407
P577
1969-12-01T00:00:00Z